By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Pevion Biotech AG 

Rehhagstrasse 79

Berne    CH-3018  Switzerland
Phone: 41-31-980-62-03 Fax: 41-31-980-66-18



Company News
Pevion Biotech AG Mandated Patient Survey Confirms Disease Burden of Recurrent Vulvovaginal Candidiasis (RVVC) and Indicates Public Health Problem 3/8/2012 11:17:31 AM
Pevion Biotech AG's Therapeutic Candida Vaccine Generates Functional B Cell Memory in all Vaccinees 1/17/2012 10:05:59 AM
Pevion Biotech AG's Therapeutic Candida Vaccine Shows Robust Systemic and Mucosal Immunogenicity, While Epidemiological Survey Confirms Excellent Market Potential 10/11/2011 10:48:48 AM
Pevion Biotech AG Grants CSL Limited (CMXHF.PK) Option Right to its Therapeutic Candida Vaccine 9/1/2011 6:22:54 AM
Pevion Biotech Ltd. Appoints New CEO and Secures CHF 10 Million ($9.9 Million) Financing 9/7/2010 6:19:02 AM
Pevion Biotech Ltd. and CEVEC Pharma Sign Exclusive License Option Agreement 5/26/2010 11:31:57 AM
Pevion Biotech Ltd.'s PEV7 Vulvovaginal Candidiasis Vaccine Enters Phase I 3/22/2010 9:32:23 AM
Positive Phase I Trial Results for Pevion Biotech Ltd.'s and Bio Life Science's Breast Cancer Vaccine 6/22/2009 12:23:24 PM
Pevion Biotech Ltd. Appoints New CEO 1/12/2009 7:35:40 AM
MYMETICS Corporation Acquires Preventive Malaria Vaccine From Pevion Biotech Ltd. 5/19/2008 8:39:32 AM